Noël A, Truchon G, Cloutier Y, Charbonneau M, Maghni K, Tardif R
1 Département de santé environnementale et de santé au travail, Institut de recherche en santé publique, Université de Montréal, Montréal, Canada.
2 Institut de recherche Robert-Sauvé en santé et en sécurité du travail (IRSST), Montréal, Canada.
Toxicol Ind Health. 2017 Apr;33(4):351-364. doi: 10.1177/0748233716651560. Epub 2016 Jul 9.
There is currently no consensus on the best exposure metric(s) for expressing nanoparticle (NP) dose. Although surface area has been extensively studied for inflammatory responses, it has not been as thoroughly validated for cytotoxicity or oxidative stress effects. Since inhaled NPs deposit and interact with lung cells based on agglomerate size, we hypothesize that mass concentration combined with aerosol size distribution is suitable for NP risk assessment. The objective of this study was to evaluate different exposure metrics for inhaled 5 nm titanium dioxide aerosols composed of small (SA < 100 nm) or large (LA > 100 nm) agglomerates at 2, 7, and 20 mg/m on rat lung inflammatory, cytotoxicity, and oxidative stress responses. We found a significant positive correlation ( r = 0.98, p < 0.01) with the inflammatory reaction, measured by the number of neutrophils and the mass concentration when considering all six (SA + LA) aerosols. This correlation was similar ( r = 0.87) for total surface area. Regarding cytotoxicity and oxidative stress responses, measured by lactate dehydrogenase and 8-isoprostane, respectively, and mass or total surface area as an exposure metric, we observed significant positive correlations only with SA aerosols for both the mass concentration and size distribution ( r > 0.91, p < 0.01), as well as for the total surface area ( r > 0.97, p < 0.01). These data show that mass or total surface area concentrations alone are insufficient to adequately predict oxidant and cytotoxic pulmonary effects. Overall, our study indicates that considering NP size distribution along with mass or total surface area concentrations contributes to a more mechanistic discrimination of pulmonary responses to NP exposure.
目前对于表达纳米颗粒(NP)剂量的最佳暴露指标尚无共识。尽管表面积已针对炎症反应进行了广泛研究,但对于细胞毒性或氧化应激效应,其验证尚不充分。由于吸入的纳米颗粒基于团聚体大小在肺部沉积并与肺细胞相互作用,我们推测质量浓度与气溶胶大小分布相结合适用于纳米颗粒风险评估。本研究的目的是评估由小(SA < 100 nm)或大(LA > 100 nm)团聚体组成的吸入性5 nm二氧化钛气溶胶在2、7和20 mg/m³时对大鼠肺部炎症、细胞毒性和氧化应激反应的不同暴露指标。我们发现,在考虑所有六种(SA + LA)气溶胶时,通过中性粒细胞数量测量的炎症反应与质量浓度之间存在显著正相关(r = 0.98,p < 0.01)。总表面积的相关性类似(r = 0.87)。关于分别通过乳酸脱氢酶和8-异前列腺素测量的细胞毒性和氧化应激反应,以及将质量或总表面积作为暴露指标,我们仅在SA气溶胶的质量浓度、大小分布(r > 0.91,p < 0.01)以及总表面积(r > 0.97,p < 0.01)方面观察到显著正相关。这些数据表明,仅质量或总表面积浓度不足以充分预测氧化剂和细胞毒性对肺部的影响。总体而言,我们的研究表明,考虑纳米颗粒大小分布以及质量或总表面积浓度有助于更深入地从机制上区分肺部对纳米颗粒暴露的反应。